Pfizer - food industry company news PfizerCompany news RSS feed

The revenue for the infant nutrition businesses totalled US$187m in 2012S AFRICA/MEXICO: Aspen buys Nestle's Mexico baby food assets

20 August 2013

South African pharmaceutical group Aspen Pharmacare has acquired Nestle's infant milk factory in Mexico and licences for some of its brands in Latin America.

In the spotlight: The verdict from China's infant formula probe

7 August 2013

International infant formula manufacturers are adjusting their business practices in China having been found guilty of price fixing. Multinational companies, which were the focus of an anti-trust investigation, say they have emerged from the probe with a "clearer understanding" of the regulatory framework in the country. However, some pundits suggest the probe must be viewed in the context of a wider government push to boost the domestic industry. Katy Askew reports.

The just-food interview part two: Nestle "best placed" to meet Chinese challenge

13 June 2013

Nestle is witnessing dynamic growth in China thanks to a combination of M&A and organic growth. As we discovered in part one of this two part interview, regional chief Roland Decorvet attributes much of this success to Nestle's use of both local and global brands. But operating in China is not without its challenges. Katy Askew caught up with Decorvet to find out more about why he believes Nestle is best-placed of all the multinationals to succeed in China.

The just-food interview part one: Nestle China CEO sees dynamic growth

13 June 2013

The potential offered by the Chinese market is nothing new. And nor is Nestle's presence in the country. The world's largest food group started trading in Hong Kong in 1874 and opened its first sales office on the mainland in 1908. In recent years Nestle has stepped up the pace with the development of a distinctive model it believes will drive expansion. In part one of the just-food interview, Roland Decorvet, chairman and CEO of Nestle Greater China, spoke to Katy Askew about the company's strategy in the market.

AFRICA/AUS: Aspen to buy Pfizer infant assets in Nestle deal

19 April 2013

Aspen Pharmacare is to acquire the Pfizer infant nutrition businesses in Australia and southern Africa after a deal with Nestle worth US$215m.

MEXICO: Nestle to sell Pfizer assets to settle competition concerns

16 April 2013

Nestle will sell Pfizer's Mexican business to settle competition issues in the market arising from its deal last year to buy the pharmaceutical giant's infant nutrition operations worldwide.

just-food confidence survey - China dominates emerging market interest

2 April 2013

just-food's Confidence Survey asked for your views on the emerging markets and, in particular, which of the BRIC economies you expected to offer the greatest opportunity in 2013. While the BRICs continued to offer opportunity for most multi-nationals, other markets such as Indonesia and Vietnam are emerging as focus markets for the future.

just-food confidence survey: M&A appetite grows but will deals be done?

2 April 2013

just-food's industry confidence survey for 2013 indicated an increased appetite for M&A this year after what some saw, globally, as a lacklustre year in the sector for deals. What lies ahead in the mergers and acquisitions arena over the next few months?

EXCLUSIVE: CAGE: Mead Johnson upbeat on China despite Nestle expansion

21 March 2013

Mead Johnson has dismissed any suggestions Nestle will prove to be formidable competition in China following the Swiss food group's acquisition of Pfizer's baby food business.

CAGE: Mead Johnson confident on 2013 despite "tough comparables"

21 March 2013

US infant nutrition group Mead Johnson says it is facing tough comparables this year due to pricing problems in China in 2012 but said it expects a rebound in growth in the back half of 2013.

CAGNY: Nestle eyes resurgence in US infant nutrition

21 February 2013

Swiss food giant Nestle has said it hopes to "come back strongly" in infant nutrition in the US, where it believes a "postponed birth spurt" could drive growth of the category.

In the spotlight: Heinz's prospects under 3G and Buffett

15 February 2013

Heinz stunned the global food industry with news it had agreed to a US$28bn takeover offer from Warren Buffett's Berkshire Hathaway fund and private-equity firm 3G Capital - purported to be the largest-ever deal in the sector. Dean Best looks at what could lie ahead for the US food giant.

Editor's choice: the highlights on just-food last week

11 February 2013

One story has dominated the industry headlines last week - the deepening and widening horse meat contamination, which has now taken in household brand Findus and a supplier in France. Beyond the debate over food standards and the scrutiny of the supply chain, Dairy Crest admitted it was struggling to find suitable M&A targets, Marks and Spencer said its Simply Food ambitions could lead them beyond France and further into Europe, while Kellogg insisted it was seeing improvement in its business in the region.

Quote, unquote: just-food's week in words

11 February 2013

Few stories in recent months have caused as much comment as the horse meat scandal, which last week deepened with the news Findus lasagne sold in the UK contained the ingredient. Elsewhere, Dairy Crest said potential takeover targets wanted too much money, Nestle found another country looking at the implications of its Pfizer infant formula acquisition and Kraft Foods Group went to court over the Cracker Barrel trademark.

SOUTH AFRICA: Competition watchdog to assess Nestle-Pfizer merger

5 February 2013

South Africa's Competition Commission will recommend the Competition Tribunal approve the South African leg of Nestle's global acquisition of Pfizer Nutrition, with a number of conditions, at a hearing tomorrow (6 February).

just-food's outlook for 2013: Mega deals unlikely as consolidation continues

31 January 2013

There may be caution over the prospect for blockbuster deals in a dilapidated economic environment, but the food sector mergers and acquisitions table still has plenty to whet the appetite.

SWITZERLAND: Nestle quiet on assets sale speculation

9 January 2013

Nestle has declined to comment on a report claiming it could sell US$1bn of assets in Latin America in order to secure final regulatory approvals for its Pfizer nutrition unit acquisition.

just-food review of 2012: M&A revival but caution hinders big deals

19 December 2012

There were, despite continued economic uncertainty in many Western markets and concerns over slowing growth in the East, signs that M&A activity rebounded in the food sector this year. However, a look at just-food's M&A coverage this year shows there have been few big-ticket, transformational deals.

MEXICO/AUS: Anti-trust concerns hit Nestle-Pfizer deal

22 November 2012

Nestle's acquisition of Pfizer's infant nutrition has been blocked by Mexico's anti-trust authority and had conditions attached to it by Australia's competition regulator.

Focus: Nestle Health Science sneaks under the radar

10 August 2012

Nestle's health science division has continued to motor below the radar in the first half of 2012 and the group is confident of a bright future for the unit.

On the money: Nestle says innovation "key" to growth in mature markets

9 August 2012

Nestle has said innovation is key to growth in developed markets where the company says achieving higher sales is "no walk in the park".

just-food Confidence Survey - emerging markets and sustainability

30 April 2012

just-food's Confidence Survey also included questions on the emerging markets and sustainability. Of the BRIC markets, China gave respondents most cause for optimism. Outside those four countries, markets from Colombia to Vietnam filled others with confidence. And, on the issue of sustainability, alleviating their company's impact on the environment remained a priority for many despite the gloomy economic landscape.

Comment: Nestle turns to emerging markets, Wal-Mart allegations hit the top

30 April 2012

Last week started with a bang, when on Monday morning (23 April) Nestle announced that it had beaten off competition from the likes of Danone to secure the baby food business of US pharmaceuticals group Pfizer.

Editor's choice: the highlights on just-food this week

30 April 2012

Allegations of bribery at Wal-Mart Stores' Mexican arm grabbed the headlines at the start of the week, rocking the world's largest retailer. Nestle, the world's largest food manufacturer, made waves of its own with its US$11.9bn deal to buy Pfizer's baby food business. The week also saw a raft of first-quarter results and the announcement of the latest results from Unilever's Sustainable Living Plan, a programme to reduce its impact on the environment. We met Unilever CEO Paul Polman to discuss the company's progress.

Quote, unquote: just-food's week in words

30 April 2012

Unilever CEO Paul Polman is one of the most prominent advocates of companies pursuing an agenda of sustainability and this week he outlined the company's progress. Meanwhile, Wal-Mart Stores was forced to react to claims of bribery in its Mexican operations and Nestle's acquisition of Pfizer's baby food business was scrutinised by analysts. The investment community also had a raft of first-quarter results to get their teeth into, with Kellogg, PepsiCo, Premier Foods plc and Hershey among the companies reporting.

CHINA: Heinz to build Sanshui baby food facility

25 April 2012

Heinz has signed an investment agreement with the government of the Sanshui district in the Chinese city of Foshan for the construction of a baby food manufacturing base.

In the spotlight: Nestle's Pfizer buy offers long-term baby food boost

23 April 2012

Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.

US: Nestle acquires Pfizer baby food arm for US$11.85bn

23 April 2012

Nestle has agreed a deal to acquire the infant nutrition business of US pharmaceuticals group Pfizer for US$11.85bn.

Comment: Nestle pays the piper with Pfizer deal

23 April 2012

Announcing its US$11.85bn acquisition of Pfizer's baby food unit this morning (23 April), it was interesting to note that Nestle took a slightly unusual tact in presenting the deal multiples.

Editor's choice: the highlights on just-food this week

23 April 2012

Tesco's plan to win back UK consumers understandably grabbed the headlines this week but there was plenty to analyse elsewhere. Nestle featured in the latest M&A speculation, with rumours that a deal to buy Pfizer's baby food unit was near and talk that it could sell its ice cream business in Australia. The food giant also kicked off the run of results announcements for the first quarter and joined Danone in outlining the challenges of operating in weak developed markets. Click on the headlines for more.

1

2

Next >

Welcome to the home of food information, insight & intelligence

Not a member? Join here